{"doi":"10.1101/2022.11.22.517559","title":"Quantitative assessment of association between noncoding variants and transcription factor binding","abstract":"Abstract Association fine-mapping of molecular traits is an essential method for understanding the impact of genetic variation. Sequencing-based assays, including RNA-seq, DNase-seq and ChIP-seq, have been widely used to measure different cellular traits and enabled genome-wide mapping of quantitative trait loci (QTLs). The disruption of cis-regulatory sequence, often occurring through variation within transcription factor binding motifs, has been strongly associated with gene dysregulation and human disease. We recently developed a computational method, TRACE, for transcription factor binding footprint prediction. TRACE integrates chromatin accessibility and transcription factor binding motifs to produce quantitative scores that describe the binding affinity of a TF for a specific TFBS locus. Here we have extended this method to incorporate variant data for 57 Yoruban individuals. Using genome-wide chromatin-accessibility data and human TF binding motifs, we have generated precise, genome-wide predictions of individual-specific transcription factor binding footprints. Subsequent association mapping between these footprints and nearby regulatory variants yielded numerous footprint-variant pairs with significant evidence for correlation, which we call footprint-QTLs (fpQTLs). fpQTLs appear to affect TF binding in a distance-dependent manner and share significant overlap with known dsQTLs and eQTLs. fpQTLs provide a rich resource for the study of regulatory variants, both within and outside known TFBSs, leading to improved functional interpretation of noncoding variation.","journal":"bioRxiv (Cold Spring Harbor Laboratory)","year":2022,"id":298928,"datarank":0.26876392038420827,"base_score":1.791759469228055,"endowment":1.791759469228055,"self_citation_contribution":0.26876392038420827,"citation_network_contribution":0.0,"self_endowment_contribution":0.26876392038420827,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":5,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.953,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":242216,"name":"Alan P. Boyle","orcid":"0000-0002-2081-1105","position":1,"is_corresponding":false},{"id":553602,"name":"Ningxin Ouyang","orcid":"0000-0002-1182-8861","position":0,"is_corresponding":true}],"reference_count":26,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T00:31:40.528568Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}